We are live on ! Find out more
CCM

Coerente Capital Management Portfolio holdings

AUM $543M
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-2.55%
1 Year Est. Return
+7.53%
3 Year Est. Return
+40%
5 Year Est. Return
+49.08%
10 Year Est. Return
AUM
$448M
AUM Growth
-$17.2M
Cap. Flow
-$3.9M
Cap. Flow %
-0.87%
Top 10 Hldgs %
58.98%
Holding
37
New
2
Increased
7
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$9.9M
2
JPM icon
JPMorgan Chase
JPM
+$1.17M
3
CVS icon
CVS Health
CVS
+$748K
4
IAT icon
iShares US Regional Banks ETF
IAT
+$369K
5
PFE icon
Pfizer
PFE
+$101K

Sector Composition

Rank Sector Weight
1 Technology 23.12%
2 Healthcare 17.77%
3 Consumer Staples 14.59%
4 Communication Services 14.08%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$41.6M 9.29%
131,865
-3,253
-2% -$1.07M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.36T
$38.9M 8.67%
297,133
-5,889
-2% -$762K
ADP icon
3
Automatic Data Processing
ADP
$106B
$25M 5.57%
103,792
-6,324
-6% -$1.54M
JNJ icon
4
Johnson & Johnson
JNJ
$618B
$23.8M 5.31%
152,873
-1,031
-0.7% -$170K
CMCSA icon
5
Comcast
CMCSA
$85B
$23.4M 5.22%
527,960
-2,580
-0.5% -$115K
ITW icon
6
Illinois Tool Works
ITW
$82.6B
$23M 5.12%
99,659
-533
-0.5% -$130K
STZ icon
7
Constellation Brands
STZ
$22.2B
$22.5M 5.01%
89,341
-559
-0.6% -$146K
PEP icon
8
PepsiCo
PEP
$190B
$22.2M 4.96%
131,152
-1,927
-1% -$350K
FISV
9
Fiserv Inc
FISV
$28.8B
$22.2M 4.95%
196,408
-6,444
-3% -$794K
ABT icon
10
Abbott
ABT
$183B
$21.9M 4.89%
226,465
-727
-0.3% -$76.4K
CL icon
11
Colgate-Palmolive
CL
$73.1B
$18.6M 4.15%
261,542
-2,331
-0.9% -$174K
SBUX icon
12
Starbucks
SBUX
$120B
$18.4M 4.1%
201,610
+334
+0.2% +$32.8K
PFE icon
13
Pfizer
PFE
$143B
$18.2M 4.05%
547,205
+2,865
+0.5% +$101K
V icon
14
Visa
V
$684B
$16.4M 3.65%
71,133
+170
+0.2% +$40.9K
AMZN icon
15
Amazon
AMZN
$2.92T
$16.1M 3.59%
126,549
+211
+0.2% +$28.3K
EOG icon
16
EOG Resources
EOG
$79.2B
$14.9M 3.32%
117,450
-5,503
-4% -$700K
CVS icon
17
CVS Health
CVS
$133B
$14.6M 3.25%
208,704
+10,550
+5% +$748K
SAP icon
18
SAP
SAP
$212B
$14.5M 3.23%
112,000
+665
+0.6% +$90.5K
USB icon
19
US Bancorp
USB
$98.2B
$11.4M 2.55%
346,181
-16,180
-4% -$589K
TFC icon
20
Truist Financial
TFC
$63.3B
$10.5M 2.33%
365,613
-37,920
-9% -$1.17M
ULTA icon
21
Ulta Beauty
ULTA
$22B
$9.04M 2.02%
+22,640
New +$9.9M
JPM icon
22
JPMorgan Chase
JPM
$935B
$5.98M 1.33%
41,252
+7,785
+23% +$1.17M
VOO icon
23
Vanguard S&P 500 ETF
VOO
$979B
$5.38M 1.2%
13,700
CVX icon
24
Chevron
CVX
$392B
$3.37M 0.75%
19,975
-1,309
-6% -$211K
PG icon
25
Procter & Gamble
PG
$336B
$1.84M 0.41%
12,615
-695
-5% -$106K

Similar funds

Coerente Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Coerente Capital Management held 37 positions worth $448M, down 3.7% from $466M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Coerente Capital Management's Q3 2023 filing shows 2 new, 7 increased, 20 reduced and 2 closed positions. Its largest new stake was Ulta Beauty: 22,640 shares worth $9.04M. The largest sale was Fomento Económico Mexicano, an estimated $7.97M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Coerente Capital Management's largest Q3 2023 buy was Ulta Beauty: 22,640 shares worth $9.04M.
  • Coerente Capital Management added most to JPMorgan Chase in Q3 2023, an estimated $1.17M increase.
  • Coerente Capital Management's biggest Q3 2023 reduction was Automatic Data Processing, cutting an estimated $1.54M.
  • Coerente Capital Management fully exited Fomento Económico Mexicano in Q3 2023, selling an estimated $7.97M.
  • Coerente Capital Management's ten largest holdings make up 59% of its $448M portfolio in Q3 2023.
  • Coerente Capital Management opened 2 new positions and closed 2 in Q3 2023.
  • Coerente Capital Management's portfolio value fell 3.7% quarter-over-quarter to $448M.

Based on Coerente Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.